FDA marks 50 years of Kefauver-Harris amendment
This year the U.S. Food and Drug Administration (FDA) is marking the anniversary of the Kefauver-Harris amendment, passed 50 years ago. The legislation gave…
Web Exclusives
New report on how mobile devices are transforming health care
May’s Issues in Technology Innovation includes the report “How Mobile Devices are Transforming Healthcare,” which includes a review of techniques for managing patients with…
Study: Family caregivers provide complex, chronic care
“Home Alone: Family Caregivers Providing Complex Chronic Care, ” from AARP and United Hospital Fund, found that almost half (46%) of family caregivers perform…
Center for nursing history gets new name
The University of Virginia School of Nursing has renamed its nursing history center to ” Eleanor Crowder Bjoring Center for Nursing Historical Inquiry. ”…
Study: Exercise may reduce food craving
A study from Brigham Young University found that 45 minutes of moderate-to-vigorous exercise in the morning reduces a person’s motivation for food. The study…
More hospital observation units could save $3.1 billion a year
“Making Greater Use Of Dedicated Hospital Observation Units For Many Short-Stay Patients Could Save $3.1 Billion A Year,” published in Health Affairs, states that…
I-Flow ON-Q Pump recall
I-Flow has recalled its ON-Q Pump with ONDEMAND Bolus Button because the button may not lock down. Read more.
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome…
Alaris Pump Module recall
CareFusion has recalled Alaris Pump Module, Models 8100 because of possible dysfunctions that could lead to pump stoppage. Read more.
FDA warns of risk of death from postop codeine use in children
On Aug. 15, the U.S. Food and Drug Administration (FDA) issued a warning about risk of death from postop codeine use in children following…
FDA approves Lucentis for diabetic macular edema
On Aug. 10, the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. Read more.
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-)…
FDA marks 50 years of Kefauver-Harris amendment
This year the U.S. Food and Drug Administration (FDA) is marking the anniversary of the Kefauver-Harris amendment, passed 50 years ago. The…
New report on how mobile devices are transforming health care
May’s Issues in Technology Innovation includes the report “How Mobile Devices are Transforming Healthcare,” which includes a review of techniques for managing…
Study: Family caregivers provide complex, chronic care
“Home Alone: Family Caregivers Providing Complex Chronic Care, ” from AARP and United Hospital Fund, found that almost half (46%) of family…
Center for nursing history gets new name
The University of Virginia School of Nursing has renamed its nursing history center to ” Eleanor Crowder Bjoring Center for Nursing Historical…
Study: Exercise may reduce food craving
A study from Brigham Young University found that 45 minutes of moderate-to-vigorous exercise in the morning reduces a person’s motivation for food.…
More hospital observation units could save $3.1 billion a year
“Making Greater Use Of Dedicated Hospital Observation Units For Many Short-Stay Patients Could Save $3.1 Billion A Year,” published in Health Affairs,…
I-Flow ON-Q Pump recall
I-Flow has recalled its ON-Q Pump with ONDEMAND Bolus Button because the button may not lock down. Read more.
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable…
Alaris Pump Module recall
CareFusion has recalled Alaris Pump Module, Models 8100 because of possible dysfunctions that could lead to pump stoppage. Read more.
FDA warns of risk of death from postop codeine use in children
On Aug. 15, the U.S. Food and Drug Administration (FDA) issued a warning about risk of death from postop codeine use in…
FDA approves Lucentis for diabetic macular edema
On Aug. 10, the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. Read…
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome…